Lora Mikolaitis Net Worth

The estimated Net Worth of Lora Mikolaitis is at least $1.61 Milione dollars as of 16 February 2018. Ms Mikolaitis owns over 115,000 units of Biosig Technologies Inc stock worth over $1,378,708 and over the last 9 years she sold BSGM stock worth over $236,250.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms Mikolaitis BSGM stock SEC Form 4 insiders trading

Ms has made over 2 trades of the Biosig Technologies Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently she sold 115,000 units of BSGM stock worth $86,250 on 16 February 2018.

The largest trade she's ever made was selling 200,000 units of Biosig Technologies Inc stock on 6 June 2017 worth over $150,000. On average, Ms trades about 45,000 units every 36 days since 2016. As of 16 February 2018 she still owns at least 3,077,474 units of Biosig Technologies Inc stock.

You can see the complete history of Ms Mikolaitis stock trades at the bottom of the page.

Ms. Lora Mikolaitis biography

Lora Mikolaitis is the VP of Admin. at Biosig Technologies Inc.

How old is Ms Mikolaitis?

Ms Mikolaitis is 48, she's been the VP of Admin. of Biosig Technologies Inc since . There are 12 older and no younger executives at Biosig Technologies Inc. The oldest executive at Biosig Technologies Inc is Dr. Budimir S. Drakulic Ph.D., 71, who is the Chief Scientist.

What's Ms Mikolaitis's mailing address?

Lora's mailing address filed with the SEC is C/O BIOSIG TECHNOLOGIES, INC., 54 WILTON ROAD, 2ND FLOOR, WESTPORT, CT, 06880.

Insiders trading at Biosig Technologies Inc

Over the last 9 years, insiders at Biosig Technologies Inc have traded over $1,778,587 worth of Biosig Technologies Inc stock and bought 1,345,515 units worth $2,296,289 . The most active insiders traders include Kenneth L Londoner, Asher Holzer e Jerome B Zeldis. On average, Biosig Technologies Inc executives and independent directors trade stock every 24 days with the average trade being worth of $11,433. The most recent stock trade was executed by Kenneth L Londoner on 13 June 2023, trading 15,600 units of BSGM stock currently worth $19,344.

What does Biosig Technologies Inc do?

biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.

Complete history of Ms Mikolaitis stock trades at Biosig Technologies Inc

Biosig Technologies Inc executives and stock owners

Biosig Technologies Inc executives and other stock owners filed with the SEC include:

• Kenneth Londoner,
  Executive Chairman of the Board, Chief Executive Officer
• Steven Chaussy,
  Chief Financial Officer
• Kenneth L. Londoner M.B.A., MBA,
  Founder, CEO & Exec. Chairman
• Samuel Navarro,
  Independent Director
• Jeffrey O'Donnell,
  Lead Independent Director
• Martha Pease,
  Independent Director
• Andrew Filler,
  Independent Director
• David Weild,
  Independent Director
• Patrick Gallagher,
  Independent Director
• Donald Foley,
  Independent Director
• Anthony Zook,
  Director
• Manasi Patwardhan,
  Director of Strategic Planning
• Olivier Chaudoir,
  Senior Director of Marketing
• Julie Stephenson,
  Vice President - Clinical Affairs, Senior Director of Clinical Affairs
• Andrew Ballou,
  Vice President - Investor Relations
• John Kowalski,
  Vice President - Sales
• John Sieckhaus,
  Chief Operating Officer
• Gray Fleming,
  Chief Commercial Officer
• Steven Chaussy,
  Chief Financial Officer
• Natasha Drapeau,
  Exec. VP
• Brenda Castrodad,
  Director of HR
• Lora Mikolaitis,
  VP of Admin.
• Dr. Budimir S. Drakulic Ph.D.,
  Chief Scientist
• Steven Eric Abelman,
  Director
• Steve Chaussy,
  Chief Financial Officer
• Roy T Tanaka,
  Director
• Lora Mikolaitis,
  10% owner
• Seth H. Z. Fischer,
  Director
• Joseph Rafferty,
  Chief Commercialization Offcr
• Jerome B Zeldis,
  Director
• Asher Holzer,
  Director
• Gregory D Cash,
  President and CEO
• James L Klein,
  Director
• James J Barry,
  Director
• John Sieckhaus,
  Chief Operating Officer
• Gray Fleming,
  Chief Commercial Officer
• Steven J Buhaly,
  Chief Financial Officer
• Frederick Hrkac,
  Director
• Donald Browne,
  Director
• Christopher Allen Baer,
  Director